Arc Antikörper (AA 191-208)
Kurzübersicht für Arc Antikörper (AA 191-208) (ABIN1886845)
Target
Alle Arc Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 191-208
-
Aufreinigung
- Affinity chromatography purified via peptide column
-
Immunogen
- Peptide corresponding to amino acids 191 to 208 of human origin.
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
-
Handhabung
- Avoid freezing and thawing repeatly.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term use.Store at -20 °C for long term preservation.
-
-
- Arc (Activity-Regulated Cytoskeleton-Associated Protein (Arc))
-
Andere Bezeichnung
- ARC
-
Hintergrund
-
Apoptosis is regulated by death domain (DD) and/or caspase recruitment domain (CARD) containing molecules and a caspase family of proteases.CARD domain containing cell death regulators include RAIDD, Apaf-1, caspase-9, and caspase-2.A novel CARD domain containing protein was recently identified and designated ARC for apoptosis repressor with CARD.ARC interacts with caspase-2 and -8 and inhibits enzymatic activity of caspase-8.ARC suppresses apoptosis induced by cell death adapters FADD and TRADD and by cell death receptors Fas, TNFR-1 and DR3.The messenger RNA of ARC is primarily expressed in skeletal muscle and cardiac tissue.
Synonyms: ARC -
Molekulargewicht
- 25 kDa
-
NCBI Accession
- NP_003937
Target
-